Listening to Your Compliance Challenges. Delivering Creative Solutions.

Create an Account

Exceeding expectations one customer at a time

Edge Pharma is an FDA registered 503B Outsourcing Facility offering high quality innovative solutions for the healthcare community. The world-class scientific, pharmacy, and engineering staff at Edge Pharma understands the challenges healthcare organizations, whether large or small, are tackling. As your compliance partner, we are dedicated to providing turnkey 503B outsourcing with the highest level of quality, easy ordering, simple logistics, and excellent customer support.

Contact Us

856 Hercules Drive,
Colchester, VT 05446

Phone: 802-992-1178
Fax: 802-489-6300

Contact Us

Careers at Edge

We are growing and looking for talented people.

Visit Careers Page

Edge Product Highlight

  • MVASITM Bevacizumab: Edge Pharma offers repackaged MVASI™ (bevacizumab-awwb) in unit-dose silicone free syringes. No vial drop-shipping means both device compliance and convenience.
  • LET Gel: Unit-dose syringes of compounded LET Gel for hospital emergency departments, urgent care centers, pediatrician offices, and other qualified health care providers. LET Gel is a topical anesthetic consisting of Lidocaine, Epinephrine, and Tetracaine.
  • Mitomycin Bladder Instillation Kit: Edge's compounded Mitomycin bladder instillation syringe kits include a 40mg/40mL pre-filled unit-dose syringe of Mitomycin, a closed system transfer device (CSTD), and catheter tip.
  • Sterile Concentrated Alum Solution: Alum bladder irrigation bag preparation is a challenge for many hospital pharmacies. Edge Pharma is excited to announce a solution that eliminates nonsterile to sterile compounding of this medication. 
  • BLT CreamBLT anesthetic cream is a topical anesthetic commonly used during minor cosmetic procedures, laser therapies, as a pre-injection topical, and a wide variety of other applications.
  • Cantharidin: Cantharidin is a chemical derived from the secretions of one of several different types of blister beetles. Edge Pharma’s Cantharidin Topical Solution has the same active ingredient as Cantharone® and Canthacur®.


LET emergency room 225

LET Gel Use in Adults

Skin lacerations account for 8.2% of trips to the Emergency Department in the U.S.(1) The goals of laceration repair are to achieve hemostatic closure and avoid infection while optimizing cosmetic outcome.(2) “While topical anesthetics are frequently used in pediatric patients requiring painful procedures, their use in adults is not as prevalent.”(2)...  [continue]


car 225

Study Examines Cataract Surgery and Car Accidents

Car accidents are considered multifactorial in cause, with driver error a contributing factor in most. About one person in 50 will be involved in a car accident in the average year. Cataracts can make it harder for a driver to see the road, street signs, other cars, and pedestrians...  [continue]


glaucoma sleep 225

Study Shows Link Between Poor Sleep and Glaucoma

A recent cross-sectional study including over 6,700 subjects investigated the relationship between glaucoma and sleep. The study results showed a connection between glaucoma and long sleep duration...  [continue]


eye health 225

Exercise May Help Prevent Eye Disease

A study at the University of Virginia School of Medicine suggests that regular exercise can prevent or slow the development of macular degeneration. Furthermore, the study indicates that exercise may also be protective against other types of vision loss, including diabetic retinopathy and glaucoma ...  [continue]


Published Study Investigates Whether a Bevacizumab Biosimilar is Safe and Effective For Ophthalmic Use

A recent study evaluating the efficacy and safety profile of a bevacizumab biosimilar indicates the biosimilar can be “safe and effective in the management of ocular conditions including Wet Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion.” The study, conducted at different tertiary eye care centers in India, was published in The International Journal of Advanced Research.   [continue]

More News ...